Redsense Medical AB (publ)
RDSNF
$0.51
-$0.54-51.43%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.12M | 2.82M | 2.99M | 2.70M | 2.29M |
| Total Other Revenue | -- | -- | -- | -100.00 | -100.00 |
| Total Revenue | 3.12M | 2.82M | 2.99M | 2.70M | 2.29M |
| Cost of Revenue | 1.28M | 1.15M | 1.18M | 1.00M | 934.40K |
| Gross Profit | 1.85M | 1.68M | 1.81M | 1.69M | 1.35M |
| SG&A Expenses | 1.68M | 1.69M | 1.75M | 1.87M | 1.88M |
| Depreciation & Amortization | 30.00K | 6.30K | 6.30K | 6.30K | 6.20K |
| Other Operating Expenses | 136.70K | 136.70K | -36.40K | -311.80K | -62.20K |
| Total Operating Expenses | 3.12M | 2.98M | 2.90M | 2.57M | 2.76M |
| Operating Income | 2.80K | -157.10K | 89.80K | 130.00K | -469.50K |
| Income Before Tax | 600.00 | -277.20K | -29.30K | 12.20K | -599.10K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 0.00 | -0.28 | -0.03 | 0.01 | -0.60 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 600.00 | -277.20K | -29.30K | 12.20K | -599.10K |
| EBIT | 2.80K | -157.10K | 89.80K | 130.00K | -469.50K |
| EBITDA | 32.80K | -150.90K | 96.10K | 136.30K | -463.30K |
| EPS Basic | -0.02 | -0.19 | -0.17 | -0.17 | -0.21 |
| Normalized Basic EPS | -0.01 | -0.12 | -0.11 | -0.11 | -0.13 |
| EPS Diluted | -0.02 | -0.19 | -0.17 | -0.17 | -0.21 |
| Normalized Diluted EPS | -0.01 | -0.12 | -0.11 | -0.11 | -0.13 |
| Average Basic Shares Outstanding | 51.23M | 51.23M | 50.41M | 47.72M | 44.73M |
| Average Diluted Shares Outstanding | 51.23M | 51.23M | 50.41M | 47.72M | 44.73M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |